Skip to content
PubMed This is a summary of 66 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 66 referenced papers

Top Authors

Matthias Eckhardt
University of Bonn
Darius Ebrahimi‐Fakhari
Boston Children's Hospital
Rebecca Schüle
German Center for Neurodegenerative Diseases
Ludger J. Schöls
German Center for Neurodegenerative Diseases
Henry Houlden
UCL Queen Square Institute of Neurology
Afshin Saffari
Boston Children's Hospital
Stephan L. Zuchner
University of Miami
Tim W. Rattay
German Center for Neurodegenerative Diseases
Florian Eichler
Harvard University
Sarah Wiethoff
University of Münster

Top Institutions

Ranked by publications Top 10 institutions
10

University of Pittsburgh

Pittsburgh, United States

10 papers

References

References (66)
  1. 1

    Neurodegeneration with brain iron accumulation.

    Gregory A, Hayflick SJ

    Folia neuropathologica 2005; (43(4)):286-96.

    PMID: 16416393
  2. 2

    A pre-test and post-test study of the physical and psychological effects of out-of-home respite care on caregivers of children with life-threatening conditions.

    Remedios C, Willenberg L, Zordan R, et al.

    Palliative medicine 2015; (29(3)):223-30 doi:10.1177/0269216314560008.

    PMID: 25634634
  3. 3

    The Crystal Structure of an Integral Membrane Fatty Acid α-Hydroxylase.

    Zhu G, Koszelak-Rosenblum M, Connelly SM, et al.

    The Journal of biological chemistry 2015; (290(50)):29820-33 doi:10.1074/jbc.M115.680124.

    PMID: 26515067
  4. 4

    Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.

    Ebrahimi-Fakhari D, Saffari A, Wahlster L, et al.

    Brain : a journal of neurology 2016; (139(Pt 2)):317-37 doi:10.1093/brain/awv371.

    PMID: 26715604
  5. 5

    Genetic and phenotypic characterization of complex hereditary spastic paraplegia.

    Kara E, Tucci A, Manzoni C, et al.

    Brain : a journal of neurology 2016; (139(Pt 7)):1904-18 doi:10.1093/brain/aww111.

    PMID: 27217339
  6. 6

    Uniparental disomy of chromosome 16 unmasks recessive mutations of FA2H/SPG35 in 4 families.

    Soehn AS, Rattay TW, Beck-Wödl S, et al.

    Neurology 2016; (87(2)):186-91 doi:10.1212/WNL.0000000000002843.

    PMID: 27316240
  7. 7

    Metachromatic Leukodystrophy: An Assessment of Disease Burden.

    Eichler FS, Cox TM, Crombez E, et al.

    Journal of child neurology 2016; (31(13)):1457-1463 doi:10.1177/0883073816656401.

    PMID: 27389394
  8. 8

    Bone Densitometry in Children and Adolescents.

    Bachrach LK, Gordon CM,

    Pediatrics 2016; (138(4)).

    PMID: 27669735
  9. 9

    Pathophysiology, diagnostic work-up and management of balance impairments and falls in patients with hereditary spastic paraplegia.

    Nonnekes J, van Lith B, van de Warrenburg BP, et al.

    Journal of rehabilitation medicine 2017; (49(5)):369-377 doi:10.2340/16501977-2227.

    PMID: 28471471
  10. 10

    Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.

    Dastsooz H, Nemati H, Fard MAF, et al.

    BMC medical genetics 2017; (18(1)):87 doi:10.1186/s12881-017-0439-y.

    PMID: 28821231
  11. 11

    Neurodegeneration with brain iron accumulation.

    Hayflick SJ, Kurian MA, Hogarth P

    Handbook of clinical neurology 2018; (147()):293-305 doi:10.1016/B978-0-444-63233-3.00019-1.

    PMID: 29325618
  12. 12

    Clinical and neuroimaging features of autosomal recessive spastic paraplegia 35 (SPG35): case reports, new mutations, and brief literature review.

    Mari F, Berti B, Romano A, et al.

    Neurogenetics 2018; (19(2)):123-130 doi:10.1007/s10048-018-0538-8.

    PMID: 29423566
  13. 13

    Botulinum Toxin-A Injection in the Treatment of Spasticity in a Infantile-Onset Neurodegeneration With Brain Iron Accumulation: A Case Report.

    Do HK, Jo GY, Kwon JK, Kim WJ

    Annals of rehabilitation medicine 2018; (42(2)):363-367 doi:10.5535/arm.2018.42.2.363.

    PMID: 29765892
  14. 14

    C. Elegans Fatty Acid Two-Hydroxylase Regulates Intestinal Homeostasis by Affecting Heptadecenoic Acid Production.

    Li Y, Wang C, Huang Y, et al.

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018; (49(3)):947-960 doi:10.1159/000493226.

    PMID: 30184537
  15. 15

    Delivering Pediatric Palliative Care: From Denial, Palliphobia, Pallilalia to Palliactive.

    Friedrichsdorf SJ, Bruera E

    Children (Basel, Switzerland) 2018; (5(9)) doi:10.3390/children5090120.

    PMID: 30200370
  16. 16

    Cerebral Iron Accumulation Is Not a Major Feature of FA2H/SPG35.

    Marelli C, Salih MA, Nguyen K, et al.

    Movement disorders clinical practice 2015; (2(1)):56-60 doi:10.1002/mdc3.12118.

    PMID: 30713878
  17. 17

    Hereditary spastic paraplegia type 35 in a family from Mali.

    Landouré G, Dembélé K, Cissé L, et al.

    American journal of medical genetics. Part A 2019; (179(7)):1122-1125 doi:10.1002/ajmg.a.61179.

    PMID: 31087769
  18. 18

    FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

    Rattay TW, Lindig T, Baets J, et al.

    Brain : a journal of neurology 2019; (142(6)):1561-1572 doi:10.1093/brain/awz102.

    PMID: 31135052
  19. 19

    Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration.

    Marshall RD, Collins A, Escolar ML, et al.

    Orphanet journal of rare diseases 2019; (14(1)):174 doi:10.1186/s13023-019-1142-1.

    PMID: 31300018
  20. 20

    Core outcome domains of pediatric palliative care for children with severe neurological impairment and their families: A qualitative interview study.

    Ribbers S, Wager J, Hartenstein-Pinter A, et al.

    Palliative medicine 2020; (34(3)):309-318 doi:10.1177/0269216319885818.

    PMID: 31680627
  21. 21

    Novel biallelic FA2H mutations in a Japanese boy with fatty acid hydroxylase-associated neurodegeneration.

    Kawaguchi M, Sassa T, Kidokoro H, et al.

    Brain & development 2020; (42(2)):217-221 doi:10.1016/j.braindev.2019.11.006.

    PMID: 31837835
  22. 22

    Shifting Tides Toward a Proactive Patient-Centered Approach in Dysphagia Management of Neurodegenerative Disease.

    Rogus-Pulia NM, Plowman EK

    American journal of speech-language pathology 2020; (29(2S)):1094-1109 doi:10.1044/2020_AJSLP-19-00136.

    PMID: 32650651
  23. 23

    Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.

    Keller SR, Mallack EJ, Rubin JP, et al.

    Journal of child neurology 2021; (36(1)):65-78 doi:10.1177/0883073820946154.

    PMID: 32875938
  24. 24

    Decreased turnover of the CNS myelin protein Opalin in a mouse model of hereditary spastic paraplegia 35.

    Hardt R, Jordans S, Winter D, et al.

    Human molecular genetics 2021; (29(22)):3616-3630 doi:10.1093/hmg/ddaa246.

    PMID: 33215680
  25. 25

    Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.

    McInerney-Leo AM, Duncan EL

    Frontiers in endocrinology 2020; (11()):628946 doi:10.3389/fendo.2020.628946.

    PMID: 33679611
  26. 26

    Childhood-onset hereditary spastic paraplegia and its treatable mimics.

    Ebrahimi-Fakhari D, Saffari A, Pearl PL

    Molecular genetics and metabolism 2022; (137(4)):436-444 doi:10.1016/j.ymgme.2021.06.006.

    PMID: 34183250
  27. 27

    Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.

    Liu Y, Teng Y, Li Z, et al.

    Clinica chimica acta; international journal of clinical chemistry 2021; (523()):163-168 doi:10.1016/j.cca.2021.09.015.

    PMID: 34560057
  28. 28

    Care practices of specialized outpatient pediatric palliative care teams in collaboration with parents: Results of participatory observations.

    Schuetze D, Ploeger C, Hach M, et al.

    Palliative medicine 2022; (36(2)):386-394 doi:10.1177/02692163211065294.

    PMID: 34927494
  29. 29

    Infantile onset ascending hereditary spastic paralysis.

    Eltoum A, O'Rourke D, Sharif F

    BMJ case reports 2022; (15(1)) doi:10.1136/bcr-2020-240941.

    PMID: 35039335
  30. 30

    Deep Brain Stimulation (DBS) with Subthalamic Nucleus (STN) as Target for Pediatric Patients with PKAN.

    Li H, Li D, Yang W, et al.

    World neurosurgery 2022; (163()):e317-e322 doi:10.1016/j.wneu.2022.03.130.

    PMID: 35367641
  31. 31

    Age-Dependent Increase in Schmidt-Lanterman Incisures and a Cadm4-Associated Membrane Skeletal Complex in Fatty Acid 2-hydroxylase Deficient Mice: a Mouse Model of Spastic Paraplegia SPG35.

    Jordans S, Hardt R, Becker I, et al.

    Molecular neurobiology 2022; (59(7)):3969-3979 doi:10.1007/s12035-022-02832-4.

    PMID: 35445918
  32. 32

    Effect of standing frames used in real life on bone remodeling in non-walking children with cerebral palsy.

    Barbier V, Goëb V, Klein C, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2022; (33(9)):2019-2025 doi:10.1007/s00198-022-06436-5.

    PMID: 35614237
  33. 33

    Percutaneous endoscopic gastrostomy and jejunostomy: Indications and techniques.

    Fugazza A, Capogreco A, Cappello A, et al.

    World journal of gastrointestinal endoscopy 2022; (14(5)):250-266 doi:10.4253/wjge.v14.i5.250.

    PMID: 35719902
  34. 34

    Palliative and Critical Care: Their Convergence in the Pediatric Intensive Care Unit.

    Buang SNH, Loh SW, Mok YH, et al.

    Frontiers in pediatrics 2022; (10()):907268 doi:10.3389/fped.2022.907268.

    PMID: 35757116
  35. 35

    A Systematic Review of Augmentative and Alternative Communication Interventions for Children Aged From 0 to 6 Years.

    Leonet O, Orcasitas-Vicandi M, Langarika-Rocafort A, et al.

    Language, speech, and hearing services in schools 2022; (53(3)):894-920 doi:10.1044/2022_LSHSS-21-00191.

    PMID: 35759607
  36. 36

    A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States.

    Peters B, O'Brien K, Fried-Oken M

    Disability and rehabilitation. Assistive technology 2024; (19(4)):1121-1134 doi:10.1080/17483107.2022.2149866.

    PMID: 36448513
  37. 37

    A new model for fatty acid hydroxylase-associated neurodegeneration reveals mitochondrial and autophagy abnormalities.

    Mandik F, Kanana Y, Rody J, et al.

    Frontiers in cell and developmental biology 2022; (10()):1000553 doi:10.3389/fcell.2022.1000553.

    PMID: 36589738
  38. 38

    Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases.

    Eckhardt M

    International journal of molecular sciences 2023; (24(5)) doi:10.3390/ijms24054908.

    PMID: 36902339
  39. 39

    Clinical, imaging and genetic profile of twenty-four patients with pantothenate kinase-associated neurodegeneration (PKAN)- A single centre study from India.

    Sriram N, Holla VV, Kumari R, et al.

    Parkinsonism & related disorders 2023; (111()):105409 doi:10.1016/j.parkreldis.2023.105409.

    PMID: 37121191
  40. 40

    Utility of genetic testing in children with leukodystrophy.

    Zerem A, Libzon S, Ben Sira L, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2023; (45()):29-35 doi:10.1016/j.ejpn.2023.05.008.

    PMID: 37267771
  41. 41

    The first reports of FA2H-associated neurodegeneration from two unrelated Iranian families.

    Hashemi N, Abadi RNS, Alavi A, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(12)):4359-4362 doi:10.1007/s10072-023-06932-4.

    PMID: 37410270
  42. 42

    Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report.

    Hameed M, Siddiqui F, Khan MK, et al.

    Brain & NeuroRehabilitation 2023; (16(3)):e25 doi:10.12786/bn.2023.16.e25.

    PMID: 38047104
  43. 43

    Novel Homozygous FA2H Variant Causing the Full Spectrum of Fatty Acid Hydroxylase-Associated Neurodegeneration (SPG35).

    German A, Jukic J, Laner A, et al.

    Genes 2023; (15(1)) doi:10.3390/genes15010014.

    PMID: 38275596
  44. 44

    Clinical and Genetic Spectrum in a Large Cohort of Hereditary Spastic Paraplegia.

    Cao Y, Zheng H, Zhu Z, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(4)):651-662 doi:10.1002/mds.29728.

    PMID: 38291924
  45. 45

    A Retrospective Review of 18 Patients With Childhood-Onset Hereditary Spastic Paraplegia, Nine With Novel Variants.

    Kilic MA, Yildiz EP, Deniz A, et al.

    Pediatric neurology 2024; (152()):189-195 doi:10.1016/j.pediatrneurol.2024.01.005.

    PMID: 38301322
  46. 46

    A Novel Homozygous Deletion Including Exon 1 of FA2H Gene Causes Spastic Paraplegia-35: Genetic and Lipidomics Analysis of the Patients.

    Mo L, Tie X, Che F, et al.

    Pediatric neurology 2024; (152()):200-208 doi:10.1016/j.pediatrneurol.2023.12.031.

    PMID: 38306901
  47. 47

    Hereditary spastic paraplegia type 35 in a Turkish girl with fatty acid hydroxylase-associated neurodegeneration.

    Engin Erdal A, Yürek B, Kıreker Köylü O, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(3)):271-275 doi:10.1515/jpem-2023-0481.

    PMID: 38353247
  48. 48

    A quantitative and qualitative analysis of patient group narratives suggests common biopsychosocial red flags of undiagnosed rare disease.

    Al-Attar M, Butterworth S, McKay L

    Orphanet journal of rare diseases 2024; (19(1)):172 doi:10.1186/s13023-024-03143-8.

    PMID: 38641814
  49. 49

    Comprehensive assessment and treatment strategies for dysphagia in the elderly population: Current status and prospects.

    Hu X, Ma YN, Karako K, et al.

    Bioscience trends 2024; (18(2)):116-126 doi:10.5582/bst.2024.01100.

    PMID: 38658363
  50. 50

    Telemedicine in nutritional management of children with severe neurological impairment: implication for quality of life.

    Tagi VM, Eletti F, Dolor J, et al.

    Frontiers in nutrition 2024; (11()):1452880 doi:10.3389/fnut.2024.1452880.

    PMID: 39224181
  51. 51

    Vitamin D prophylaxis in persons with epilepsy?

    Sourbron J, Auvin S, Cabral-Lim L, et al.

    Epilepsia 2024; (65(9)):2567-2579 doi:10.1111/epi.18046.

    PMID: 39494692
  52. 52

    POLR3-Related Leukodystrophy: A Qualitative Study on Parents' Experiences With the Health Care System.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2025; (166()):81-87 doi:10.1016/j.pediatrneurol.2025.02.011.

    PMID: 40106878
  53. 53

    French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

    Mania-Pâris L, Ewenczyk C, Nicolas G, et al.

    Revue neurologique 2025; (181(6)):471-482 doi:10.1016/j.neurol.2025.05.001.

    PMID: 40450402
  54. 54

    [FA2H gene-associated spastic paraplegia (SPG35) - familial case with late onset].

    Rudenskaya GE, Bostanova FM, Zabnenkova VV, et al.

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2025; (125(5)):137-144 doi:10.17116/jnevro2025125051137.

    PMID: 40457680
  55. 55

    Prescribing Assistive Technology: Focus on Children With Complex Communication Needs: Clinical Report.

    Desch LW, Hobart-Porter LJ, Houtrow A,

    Pediatrics 2025; (156(1)) doi:10.1542/peds.2025-072216.

    PMID: 40518139
  56. 56

    Neurodegeneration with Brain Iron Accumulation.

    Schipper DA, Schipper HM

    Advances in experimental medicine and biology 2025; (1480()):291-309 doi:10.1007/978-3-031-92033-2_19.

    PMID: 40603798
  57. 57

    The impact of leukodystrophies on parents' lives.

    Zampini L, Cordolcini L, Draghi L, et al.

    Journal of pediatric psychology 2025; (50(12)):1091-1098 doi:10.1093/jpepsy/jsaf072.

    PMID: 40853273
  58. 58

    Disrupted Myelination in FAHN: Insights from a Patient-Specific hiPSC Neuron-Oligodendrocyte Model.

    Efendic F, Hermann A, Frech MJ

    Cells 2025; (14(16)) doi:10.3390/cells14161261.

    PMID: 40862740
  59. 59

    An atypical case of FA2H-related HSP35 with subtle neuroimaging findings and a novel variant in a young adult with spastic paraparesis.

    Roy S, Mailankody P, Arunachal G, et al.

    Acta neurologica Belgica 2026; (126(1)):277-281 doi:10.1007/s13760-025-02899-5.

    PMID: 41006743
  60. 60

    Fractures in Children With Cerebral Palsy: A Systematic Review.

    Bentley LA, Taylor MJ, Brookes DSK, et al.

    Pediatrics 2026; (157(1)) doi:10.1542/peds.2025-072946.

    PMID: 41344381
  61. 61

    Clinical, Radiological, and Genetic Profile of Patients with FA2H-Associated Neurodegeneration: Eight Cases from India and a Review of the Literature.

    Holla VV, Kumari R, Sriram N, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2026; (16()):15 doi:10.5334/tohm.1162.

    PMID: 41798181
  62. 62

    Deep brain stimulation for the treatment of paediatric dystonia due to neuroanatomical abnormalities: a systematic review of efficacy and future perspectives.

    Soliman Y, Figliomeni A, Lee H, et al.

    BMJ neurology open 2026; (8(1)):e001543 doi:10.1136/bmjno-2025-001543.

    PMID: 42158588
  63. 63

    Beyond standard care: Fathers' perspectives on healthcare and related support services when caring for a child with a progressive life-limiting condition-A qualitative study.

    Sjuls M, Ludvigsen MS, Fegran L, Robstad N

    Palliative medicine 2026; 2692163261486220 doi:10.1177/02692163261486220.

    PMID: 42811452
  64. 64

    A Rare Case of Fatty Acid Hydroxylase-Associated Neurodegeneration in a Pakistani Boy With a Homozygous FA2H Variant.

    Siddiqui AN, Siddiqui YN, Abbasi NUH, et al.

    Clinical case reports 2026; (14(10)):e73559 doi:10.1002/ccr3.73559.

    PMID: 42812484
  65. 65

    Hereditary spastic paraplegia: a practical approach.

    Bradley M, Kalfat A, Walsh RA, et al.

    Practical neurology 2026; doi:10.1136/pn-2026-005344.

    PMID: 42816178
  66. 66

    Rehabilitation management of children with hereditary spastic paraplegia: a retrospective cohort study.

    Paget SP, McIntyre S, Lewis J, et al.

    Developmental neurorehabilitation 2026; 1-8 doi:10.1080/17518423.2026.2738682.

    PMID: 42831377